MoneyWorks4Me

Cipla board to consider unaudited financial results

29 Jan 2013 Evaluate
Cipla has informed that a meeting of the board of directors of the company will be held on February 06, 2013, to consider unaudited financial results for third quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..